JP Morgan Chase
COYA icon

JP Morgan Chase’s Coya Therapeutics COYA Stock Holding History

JP Morgan Chase’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4K Buy
5,181
+181
+4% +$838 ﹤0.01% 6601
2026
Q1 		$18.9K Hold
5,000
– – ﹤0.01% 6565
2025
Q4 		$29K Hold
5,000
– – ﹤0.01% 6422
2025
Q3 		$28.5K Buy
+5,000
New +$30.4K ﹤0.01% 6393
2025
Q1 		– Sell
-32
Closed -$183 – 7370
2024
Q4 		$183 Buy
32
+1
+3% +$7 ﹤0.01% 6924
2024
Q3 		$200 Sell
31
-1
-3% -$6 ﹤0.01% 6905
2024
Q2 		$194 Sell
32
-498
-94% -$4K ﹤0.01% 6791
2024
Q1 		$5.26K Buy
530
+465
+715% +$3.64K ﹤0.01% 6443
2023
Q4 		$482 Buy
65
+60
+1,200% +$333 ﹤0.01% 6934
2023
Q3 		$19 Buy
+5
New +$20 ﹤0.01% 7173

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

JP Morgan Chase's COYA Position: Q2 2026 in Review

JP Morgan Chase increased its Coya Therapeutics (COYA) stake by 3.6% in Q2 2026, buying an estimated $838 and bringing the position to 5,181 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6601.

JP Morgan Chase first reported a position in COYA in Q3 2023 and has held it in 10 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • JP Morgan Chase held 5,181 shares of Coya Therapeutics worth $31.4K as of Q2 2026.
  • JP Morgan Chase bought 181 Coya Therapeutics shares in Q2 2026, an estimated $838.
  • Coya Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6601 holding.
  • JP Morgan Chase first reported a position in Coya Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.